357 related articles for article (PubMed ID: 11433225)
21. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
22. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
[TBL] [Abstract][Full Text] [Related]
23. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
24. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
[TBL] [Abstract][Full Text] [Related]
25. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
Lei Q; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
[TBL] [Abstract][Full Text] [Related]
26. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.
Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
Blood; 2015 Jan; 125(1):155-61. PubMed ID: 25342714
[TBL] [Abstract][Full Text] [Related]
27. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
28. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of heparin-induced thrombocytopenia and thrombosis.
Arepally G; Cines DB
Autoimmun Rev; 2002 May; 1(3):125-32. PubMed ID: 12849005
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
[TBL] [Abstract][Full Text] [Related]
31. Heparin-induced thrombocytopenia and thrombosis.
Arepally G; Cines DB
Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
[No Abstract] [Full Text] [Related]
32. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
34. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
35. Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
Bakchoul T; Assfalg V; Zöllner H; Evert M; Novotny A; Matevossian E; Friess H; Hartmann D; Hron G; Althaus K; Greinacher A; Hüser N
J Thromb Haemost; 2014 Jun; 12(6):871-8. PubMed ID: 24655935
[TBL] [Abstract][Full Text] [Related]
36. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
[TBL] [Abstract][Full Text] [Related]
38. CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer.
Sandset PM
Thromb Res; 2012 Apr; 129 Suppl 1():S97-100. PubMed ID: 22682144
[TBL] [Abstract][Full Text] [Related]
39. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
40. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]